It has been demonstrated that the miR-577/POSTN axis controls the downstream ILK/AKT/mTOR signaling pathway through the METTL3-mediated overexpression of lnc00520 to accelerate the development of breast cancer [33]. The gene discussed is METTL3; the disease is breast carcinoma.